Drug Type Small molecule drug |
Synonyms ABBV-1088 |
Target |
Action inhibitors |
Mechanism PINK1 inhibitors(PTEN induced kinase 1 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Parkinson Disease | Phase 1 | United States | 01 May 2024 |





